scispace - formally typeset
J

Jane Kaye

Researcher at University of Oxford

Publications -  151
Citations -  24672

Jane Kaye is an academic researcher from University of Oxford. The author has contributed to research in topics: Biobank & Data sharing. The author has an hindex of 42, co-authored 145 publications receiving 18345 citations. Previous affiliations of Jane Kaye include University of Malaya & Mount Vernon Hospital.

Papers
More filters
Journal ArticleDOI

eRegistries: governance for electronic maternal and child health registries.

TL;DR: This research utilizes findings from two web-based surveys, completed in 2015 that targeted public health officials and health care providers in 76 countries with high global maternal and child mortality burden and found that the prevailing legal landscape is characterized by inadequate data security safeguards and weak support for core privacy principles.
Journal ArticleDOI

Australian Aboriginal and Torres Strait Islander Collections of Genetic Heritage: The Legal, Ethical and Practical Considerations of a Dynamic Consent Approach to Decision Making.

TL;DR: Dynamic consent (DC) as mentioned in this paper is both a model and a specific web-based tool that enables clear, granular communication and recording of participant consent choices over time, and it enables individual consent choices to be expressed and recorded over time.
Journal ArticleDOI

Can i access my personal genome? the current legal position in the uk

TL;DR: The authors describe the policy implications in this area and conclude that, for now, the law appears to strike an appropriate balance, but new policy will need to be developed to address this issue.
Journal ArticleDOI

Genetic testing without consent: the implications of the new Human Tissue Act 2004

TL;DR: Despite its focus on consent the new Human Tissue Act 2004 allows for testing without consent where a relative could benefit, and should take measures to limit the potential harm that can be caused.
Journal ArticleDOI

Exploring the potential duty of care in clinical genomics under UK law.

TL;DR: The way that UK law may respond to three key challenges of genome-wide sequencing is explored and new legal duties in relation to feedback of findings that are unrelated to the presenting condition are established.